Following that, proteomic research of several cancers indicated that TLRs interacted with a variety of proteins implicated in tumour-linked pathways such as RTK/RAS, TP53, NF-B, WNT, MYC, and cell cycle pathways, etc. (See Figure S6). This evidence concerns the gene TP53 and cancer.